Cell Line Development
Integrating Cell Line and CMC Development
Stephen Hamilton, Ph.D.; Mike Brem
Wheeler Bio
PAO-06-022-CL-12Sep 02, 2022
ADCS
Improving the Therapeutic Index of ADCs with a Peptide Linker Technology
Philipp Spycher
Araris Biotech AG
PAO-07-022-CL-01Jul 07, 2022
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06Jul 02, 2022
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12Jun 24, 2022
Column: New Drug Watch
New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-08Jun 24, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02Jun 24, 2022
Column: Regulatory Spotlight
The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-05Jun 24, 2022
NFTs
Digital Frontiers: What NFTs Can Do for Pharma
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-01Jun 24, 2022
Column: Supply Chain
Creating a More Resilient Pharmaceutical Supply Chain One Segment at a Time
Tonia Becker
Nice Insight
PAO-06-022--NI-09Jun 24, 2022
Mental Health
Mental Health During a Global Pandemic
Marc Technow
Nice Insight
PAO-06-022--NI-03Jun 24, 2022
Biotechs
10 More Biotechs Making Moves in 2022
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-07Jun 24, 2022
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-04Jun 24, 2022
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Pharma's Almanac
PAO-06-022--RT-01Jun 24, 2022
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01Jun 24, 2022
Quantum Computing
Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-10Jun 24, 2022
API
Small Molecule API Market Trends
James Grote
Nice Insight
PAO-06-022--NI-11Jun 24, 2022
Real-World Data
Real-World Data and Artificial Intelligence are Transforming Clinical Development
Jeff Elton, Ph.D.
ConcertAI
PAO-06-022-CL-09Jun 21, 2022
Cell and Gene Therapy Analytics
Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support
Hui Chen, Ph.D.
Porton Advanced Solutions
PAO-06-022-CL-07Jun 21, 2022
Rare Diseases
Staying Agile to Bring Therapies to Patients with Rare Diseases
Sheila Frame
Amryt Pharma
PAO-06-022-CL-08Jun 21, 2022
Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
Kiren Khanduga; Alicia Levey, Ph.D.
Pionyr Immunotherapeutics
PAO-06-022-CL-04Jun 06, 2022